市场调查报告书
商品编码
1503350
2030 年生物资讯市场预测:按产品、应用、最终用户和地区进行的全球分析Bioinformatics Market Forecasts to 2030 - Global Analysis By Product (Bioinformatics Platforms, Bioinformatics Services and Other Products), Application, End User and By Geography |
根据Stratistics MRC预测,2024年全球生物资讯学市场规模将达133亿美元,预计2030年将达到308亿美元,预测期内复合年增长率为15.0%。
生物资讯学是结合生物学、电脑科学和资讯技术来分析和解释生物资料的跨学科领域。它涉及开发演算法、软体工具和资料库来储存、管理和分析大量生物资料,如 DNA 序列、蛋白质结构和基因表现。生物资讯学在生物研究的各个领域发挥着重要作用,包括基因组学、蛋白质组学、演化生物学和药物发现。透过利用计算和统计技术,生物资讯学使研究人员能够深入了解生物过程,了解疾病机制,开发新的治疗方法,并最终加深对科学和医学的理解。
根据史丹佛医学2022年1月发表的报导称,史丹佛大学科学家进行的研究表明,DNA序列测定技术可以在大约8小时内对人类基因组序列测定。
对次世代定序仪(NGS) 的需求迅速成长,资料量不断增加
次世代定序仪产生大量复杂资料,包括 DNA 和蛋白质序列。如果没有适当的分析和解释,这些资料本质上就毫无意义。生物资讯工具对于理解这些资料、识别模式和得出有价值的见解至关重要。此外,云端处理为储存和分析 NGS资料提供了可扩展且经济高效的解决方案。这种云端基础的生物资讯学工具的成长正在进一步扩大市场,并使这些强大的资源更容易获得,从而推动市场成长。
生物资讯学工具和服务高成本
这些工具的复杂性,加上分析资料所需的运算资源,导致其价格飙升。因此,预算有限的小型研究机构、学术实验室和生物技术新兴企业面临着获取和利用先进生物资讯解决方案的挑战。这种获取机会的差异可能会限制该领域不同相关人员的参与并阻碍市场成长,从而阻碍协作研究、创新和科学进步。
精准医疗和个人化医疗保健的兴起
个人化医疗保健方法需要对个人遗传、分子和临床资料进行详细分析,以便根据患者的独特特征和需求量身定制治疗方案。生物资讯学在大型生物和医学资料集的处理、分析和解释中发挥核心作用,能够识别生物标记、疾病亚型和治疗标靶。随着精准医疗在肿瘤学、循环系统和神经病学等各个医学领域变得普及,对先进生物资讯学工具和服务的需求呈指数级增长。
缺乏熟练的生物资讯学专业人员
随着对生物资讯工具和服务的需求增加,对计算生物学、资料分析和程式设计专家的需求也在增加。然而,该专业合格专业人员的供应往往低于行业需求。这种不足可能会延迟研究计划,降低资料分析的效率,并增加寻求利用生物资讯解决方案的组织的成本。
COVID-19 的影响
由于迫切需要了解病毒的基因组结构、感染模式和药物开发,因此生物资讯学工具和专业知识至关重要。这增加了对分析 COVID-19 相关资料的生物资讯解决方案的需求,例如基因组序列测定、蛋白质建模和流行病学研究。此外,大流行期间研究活动的中断和资金筹措挑战影响了非新冠研究领域中生物资讯工具的采用。
分子系统发育部分预计在预测期内将是最大的
分子系统发育学预计将在预测期内达到最大规模,因为它严重依赖生物资讯工具和演算法来进行 DNA 和蛋白质序列分析、系统发育树建构和演化建模。随着分子系统学在进化生物学、生物多样性保护和感染疾病研究等各种科学领域中发挥重要作用,对先进生物资讯解决方案的需求持续增长。
动植物生物技术领域预计在预测期内复合年增长率最高。
由于农业、製药和环境保护领域越来越多地采用生物技术方法,动植物生物技术产业将在预测期内继续增长,预计对专门用于动植物基因组资料分析的生物资讯解决方案的需求将会增加。这一趋势正在刺激生物资讯软体、资料库和演算法的创新,旨在支持动植物生物技术研究和应用,刺激市场成长。
预计北美在预测期内将占据最大的市场占有率,因为该地区对生物资讯学工具和服务的需求很高,重点关注精准医疗、个人化医疗和基因组研究。技术进步、政府措施以及学术界和工业界之间的战略合作等关键因素正在进一步推动市场成长。此外,製药和生物技术公司越来越多地采用生物资讯学也有助于市场扩张。
由于增加医疗基础设施投资、增加先进技术的采用以及扩大生命科学领域的研发活动等因素,亚太地区预计在预测期内将保持最高的复合年增长率。中国、印度、日本和韩国等国家在基因组学、蛋白质组学和个人化医疗方面取得了重大进展,推动了对生物资讯解决方案的需求。此外,该地区製药和生物技术行业的快速增长也促进了生物资讯学工具和服务的日益采用。
According to Stratistics MRC, the Global Bioinformatics Market is accounted for $13.3 billion in 2024 and is expected to reach $30.8 billion by 2030 growing at a CAGR of 15.0% during the forecast period. Bioinformatics is an interdisciplinary field that combines biology, computer science, and information technology to analyze and interpret biological data. It involves developing algorithms, software tools, and databases to store, manage, and analyze large volumes of biological data, such as DNA sequences, protein structures, and gene expressions. Bioinformatics plays a crucial role in various areas of biological research, including genomics, proteomics, evolutionary biology, and drug discovery. By leveraging computational techniques and statistical methods, bioinformatics enables researchers to gain insights into biological processes, understand disease mechanisms, and develop novel therapies, ultimately advancing understanding of life sciences and medicine.
According to an article published by Stanford Medicine in January 2022, research conducted by Stanford scientists showed that a DNA sequencing technique could sequence a human genome in about 8 hours.
Surging demand for next-generation sequencing (NGS) and growing data volume
Next-generation sequencing generates massive amounts of complex data, including DNA and protein sequences. This data is essentially meaningless without proper analysis and interpretation. Bioinformatics tools are essential for making sense of this data, identifying patterns, and extracting valuable insights. Moreover cloud computing offers a scalable and cost-effective solution for storing and analyzing NGS data. This growth in cloud-based bioinformatics tools further expands the market and makes these powerful resources more accessible driving the growth of the market.
High cost of bioinformatics tools and services
The sophisticated nature of these tools, coupled with the computational resources required for data analysis, contributes to their elevated pricing. As a result, smaller research institutions, academic labs, and biotech startups with limited budgets may face challenges accessing and utilizing advanced bioinformatics solutions. This disparity in access can hinder collaboration, innovation, and scientific progress, as it limits the participation of diverse stakeholders in the field hampering the market growth.
Rise of precision medicine and personalized healthcare
Personalized healthcare approaches require detailed analysis of individual genetic, molecular, and clinical data to tailor treatments to patients' specific characteristics and needs. Bioinformatics plays a central role in processing, analyzing, and interpreting large-scale biological and medical data sets, enabling the identification of biomarkers, disease subtypes, and therapeutic targets. As precision medicine gains traction in various medical fields, including oncology, cardiology, and neurology, the demand for advanced bioinformatics tools and services grows exponentially.
Shortage of skilled bioinformatics professionals
As the demand for bioinformatics tools and services increases, there is a parallel need for experts proficient in computational biology, data analysis, and programming. However, the supply of qualified professionals in this specialized field often falls short of industry demands. This shortage can result in delays in research projects, reduced efficiency in data analysis, and increased costs for organizations seeking to utilize bioinformatics solutions.
Covid-19 Impact
The urgent need for understanding the virus's genomic structure, transmission patterns, and drug development, bioinformatics tools and expertise became crucial. This led to increased demand for bioinformatics solutions for analyzing COVID-19-related data, such as genomic sequencing, protein modeling, and epidemiological studies. Additionally, disruptions in research activities and funding challenges during the pandemic affected the adoption of bioinformatics tools in non-COVID research areas.
The molecular phylogenetics segment is expected to be the largest during the forecast period
The molecular phylogenetics is expected to be the largest during the forecast period as it relies heavily on bioinformatics tools and algorithms for DNA and protein sequence analysis, phylogenetic tree construction, and evolutionary modeling. As molecular phylogenetics plays a crucial role in various scientific disciplines such as evolutionary biology, biodiversity conservation, and infectious disease research, the demand for advanced bioinformatics solutions continues to grow.
The animal & plant biotechnology segment is expected to have the highest CAGR during the forecast period
The animal & plant biotechnology segment is expected to have the highest CAGR during the forecast period owing to increasing adoption of biotechnological approaches in agriculture, pharmaceuticals, and environmental conservation fuels the need for bioinformatics solutions tailored to animal and plant genomic data analysis. This trend stimulates market growth by spurring innovation in bioinformatics software, databases, and algorithms designed to support animal and plant biotechnology research and applications, thereby expanding opportunities and driving advancements in the bioinformatics market.
North America is projected to hold the largest market share during the forecast period due to a focus on precision medicine, personalized healthcare, and genomic research, the region witnesses' high demand for bioinformatics tools and services. Key factors such as technological advancements, government initiatives, and strategic collaborations between academia and industry further propel market growth. Additionally, the increasing adoption of bioinformatics in pharmaceutical and biotechnology companies contributes to the market's expansion.
Asia Pacific is projected to hold the highest CAGR over the forecast period due to factors such as increasing investments in healthcare infrastructure, rising adoption of advanced technologies, and expanding research and development activities in life sciences. Countries like China, India, Japan, and South Korea are witnessing significant advancements in genomics, proteomics, and personalized medicine, fueling demand for bioinformatics solutions. Additionally the region's burgeoning pharmaceutical and biotechnology sectors also contribute to the expanding adoption of bioinformatics tools and services.
Key players in the market
Some of the key players in Bioinformatics market include ABM, Agilent Technologies, BGI Group, Biowisdom Co., Ltd., Dassault Systemes, DNAnexus Inc., Fios Genomics, Geneva Bioinformatics SA, Illumina, Lineage Cell Therapeutics, NeoGenomics Laboratories, Ontopos, Partek Inc., PerkinElmer, Qiagen, Seven Bridges Genomics, Source BioScience, Thermo Fisher Scientific and Waters Corporation
In June 2024, Valeo Partners with Dassault Systemes to Accelerate the Digitalization of Its R&D. Valeo will deploy Dassault Systemes' 3DEXPERIENCE platform to optimize the development of new technologies for safer and more sustainable mobility
In May 2024, JLR and Dassault Systemes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide. The 3DEXPERIENCE platform connects all stakeholders in one collaborative virtual environment, leveraging the latest technological innovation
In March 2024, Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024. The new mass spectrometry and chromatography instruments and software solutions enable customers to unlock deeper analytical insights with built-for-purpose flexibility
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.